These findings are in accordance with studies done in melanoma and non-small cell lung cancer which define the feedback networks responsible for limiting MEK dependence in these cancers and the pathway mutations capable of disabling these networks3,36–40. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.